Pulsethera is developing a novel phototherapy platform as an alternative to antimicrobial drugs, which microbes could become resistant to in as short as one year. Regardless of antibiotic resistance status, our approach manipulates the physical properties of microbes’ key enzymes to render the organism susceptible to killing.
Intellectual Property – issued and allowed US patent claims for phototherapy and inanimate surface disinfection; pending US and international applications.
The potential of Pulsethera’s technology may change how we treat life threating infections …